SCHEMBL4359745

SCHEMBL4359745

O=C(NCc1ccc(C(F)(F)F)cc1)N(S)c1cc(Cl)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS4 Q9NRS4 3/20 0.50
P2RX1 P51575 2/20 0.50
P2RX4 Q99571 1/20 0.44
P2RX7 Q99572 1/20 0.44
CHRNA7 P36544 1/20 0.43
MTOR P42345 1/20 0.43
LSS P48449 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PTGER4 P35408 1/20 0.42
ERCC1 P07992 3/20 0.41
ERCC4 Q92889 3/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351483 0.85 MTOR (0.42) TMPRSS4P2RX1MTORLSSHDAC3
SCHEMBL4353933 0.82 TMPRSS4 (0.60) TMPRSS4P2RX1P2RX4P2RX7CHRNA7
SCHEMBL4357663 0.81 HDAC1 (0.44) TMPRSS4P2RX1CHRNA7MTORLSS
SCHEMBL4348897 0.81 MTOR (0.50) P2RX7MTORLSSHDAC3HDAC1
SCHEMBL4345514 0.81 MTOR (0.38) TMPRSS4P2RX1MTORLSSHDAC3
SCHEMBL4347804 0.80 KCNH2 (0.39) MTORLSSHDAC3HDAC1HDAC2
SCHEMBL4347497 0.79 MAPT (0.47) TMPRSS4P2RX1P2RX4P2RX7MTOR
SCHEMBL4357500 0.79 HDAC3 (0.46) TMPRSS4P2RX1MTORLSSHDAC3
SCHEMBL3300941 0.78 P2RX1 (0.48) TMPRSS4P2RX1MTORHDAC3HDAC1
SCHEMBL4355927 0.78 LSS (0.44) P2RX7MTORLSSHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 TMPRSS4 630/4885P2RX1 2577/4885P2RX4 2254/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 TMPRSS4 379/4885P2RX1 2600/4885P2RX4 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.